USC researcher named General Motors Cancer Research Scholar

LOS ANGELES, June 29, 2004 Judd Rice, Ph.D., Assistant Professor of Biochemistry and Molecular Biology at the USC/Norris Comprehensive Cancer Center and the Keck School of Medicine of USC, has been named one of five General Motors Cancer Research Scholars for 2004.

Along with the two-year, $200,000 grant given to Rice, USC/Norris Comprehensive Cancer Center also receives a 2004 or 2005 General Motors vehicle of its choice, worth up to $31,000. The vehicle will be raffled off at a later date to raise funds for programs at USC/Norris.

Rice, who joined USC in 2003 from the University of Virginia, Charlottesville, received the grant for his research looking at the ways in which changes in the structure of chromatin the gnarled strands of protein and DNA found in a cell's nucleus contribute to the development and progression of sporadic breast cancers. (Sporadic breast cancers are those that are not directly associated with a specific genetic mutation.)

Rice's work at the Keck School is concentrated on so-called epigenetic gene regulation the heritable on and off switches of genes that are associated with chemical modifications to the DNA and proteins in the nucleus that will ultimately make a difference in the understanding and treatment of cancer.

A native of Phoenix, Ariz., Rice earned his doctorate in pharmacology and toxicology from the University of Arizona, Tucson. He currently resides in San Gabriel, Calif.

The GM Cancer Research Scholars Program began in 2001 and provides $1 million per year to support the ongoing research projects of young scientists early in their careers. The program is open to members of the more than 40 Comprehensive Cancer Centers designated by the National Cancer Institute. Each Center may nominate one candidate per year for an award.

In 2002, USC/Norris researcher Christopher A. Haiman was selected as a GM Cancer Research Scholar for his work on the genetic determinants of brea

Contact: Sarah Huoh
University of Southern California

Page: 1 2

Related biology news :

1. Belgian researchers explore revolutionary approach to angiogenesis
2. Award winning researchers reveal potential new role for Glivec
3. University of Alberta researcher looks for clues to mysterious disease
4. $7.5 Million grant to Yale researchers for role of viruses in cancer
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Joslin researchers clarify mechanisms for beta-cell formation
7. Pioneering AIDS researcher to speak at UH
8. Defensive action by influenza viruses demonstrated by Hebrew university researcher
9. Virginia Tech researchers to release findings on Smith River Project
10. Molecular motor myosin VI moves hand over hand, researchers say
11. Tiny molecules have big potential as cancer drugs, Stanford researcher believes

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: